The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of the survival benefit from metformin use in patients with type 2 diabetes and colorectal cancer.
Ibrahim Halil Sahin
No relevant relationships to disclose
Hesham Mohamed Hassabo
No relevant relationships to disclose
Yehua Shen
No relevant relationships to disclose
Bryan K. Kee
No relevant relationships to disclose
Manal Hassan
No relevant relationships to disclose
Chris R. Garrett
No relevant relationships to disclose